Check myositis‐specific autoantibodies (anti‐MDA5, anti‐TIF1‐γ, and anti‐NXP2), inflammatory markers (ESR, CRP, and ferritin), imaging, endoscopy, and tumor markers. This evidence concerns the gene IFIH1 and neoplasm.